Pyruvate Kinase Activation

  • 2 Replies
Pyruvate Kinase Activation
« on: March 15, 2022, 07:02:59 PM »
Would this give credence to the theory of iron, before, the manifestation of Thalassemia?
Since iron inhibits pyruvate kinase?

The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model

Iron-Dependent Oxidative Inactivation with Affinity Cleavage of Pyruvate Kinase.

Re: Pyruvate Kinase Activation
« Reply #1 on: March 20, 2022, 07:22:26 PM »
This looks interesting. Is this treatment in the market now ?


Offline Andy Battaglia

  • *****
  • 8793
  • Gender: Male
  • Will thal rule you or will you rule thal?
Re: Pyruvate Kinase Activation
« Reply #2 on: March 23, 2022, 04:55:57 AM »
It was just approved in the US in February, 2022.

On February 17, 2022, the FDA approved mitapivat as the first disease-modifying treatment for hemolytic anemia in adults with pyruvate kinase (PK) deficiency, a rare, inherited disorder leading to lifelong hemolytic anemia.6 Mitapivat has also been investigated in other hereditary red blood cell disorders associated with hemolytic anemia, such as sickle cell disease and alpha- and beta-thalassemia.1

All we are saying is give thals a chance.


SMF spam blocked by CleanTalk